CATALYTAC Trademark
CATALYTAC is a USPTO trademark filed by Lycia Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | CATALYTAC |
|---|---|
| Serial Number | 98840485 |
| Status | Pending |
| Filing Date | 2024-11-06 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT), 044 (Medical Services) |
| Owner | Lycia Therapeutics, Inc. |
| Attorney of Record | Connie L. Ellerbach |
| Prosecution Events | 13 |
| Latest Event | RCCK on 2026-04-29 |
Goods & Services
Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases, neurological diseases, and other human diseases; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals; Providing medical information; Providing medical information via a website; Medical services; Medical diagnostic testing, medical clinics, medical screenings, medical examinations and medical treatment services; Provision of pharmaceutical information; Pharmaceutical services, consultations and advice; Research and development services in the field of pharmaceuticals; drug discovery services